propantheline has been researched along with Diabetic Retinopathy in 1 studies
Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyer, SL | 1 |
| Sharp, PS | 1 |
| Brooks, RA | 1 |
| Burrin, JM | 1 |
| Kohner, EM | 1 |
1 trial available for propantheline and Diabetic Retinopathy
| Article | Year |
|---|---|
Failure to suppress GH secretion after 2 weeks treatment with atropine or propanthelene in diabetics with proliferative retinopathy.
Topics: Adult; Atropine; Blood Glucose; Diabetic Retinopathy; Female; Growth Hormone; Humans; Male; Middle A | 1988 |